67
Participants
Start Date
June 12, 2023
Primary Completion Date
April 8, 2025
Study Completion Date
May 31, 2029
GNSC-001
intra-articular injection
transient immune-modulation
oral
transient immune-modulation
intra-articular injection
Placebo
intra-articular injection
Altoona Center for Clinical Research, Duncansville
West Clinical Research, Morehead City
Premier Medical Associates, The Villages
South Florida Research, Miami Springs
Well Pharma Medical Research, Miami
Alliance for Medical Research Mobile, Mobile
Alliance for Multispecialty Research Kansas City, Kansas City
Biosolutions Clinical Research Center, La Mesa
UC San Diego, San Diego
Lead Sponsor
California Institute for Regenerative Medicine (CIRM)
OTHER
Genascence Corporation
INDUSTRY